Recently, Sunsight Technology, a company specializing in AI-powered ultrasound brain-computer interfaces, proudly announced the successful closure of its seed+ funding round, raising tens of millions of yuan. This pivotal funding round was spearheaded by China Auto Investment, with significant contributions from Wise Road Capital and the Global Health Industry Innovation Center (GHIC). Notably, existing shareholders, such as the Inno Science and Technology Innovation Fund and the Tsinghua University Alumni Seed Fund, also demonstrated their confidence by further increasing their investments. Everbright Capital played a crucial role as the exclusive financial advisor in this process. The newly acquired funds will be strategically allocated towards core technology research and development, the progression of medical device products, the establishment of a multimodal brain data and AI brain science platform, as well as the expansion and enrichment of the talent team.